ss all phases of drug development. In addition
to offering the Pain Clinic Monitor, the firm continues to expand its line of
pain-related, multi-client Enhanced Perspective publications, with its 2008
U.S. Neuropathic Pain Report, featuring two new chapters -- Fibromyalgia and
Neuropathic Cancer Pain. Two additional pain-related reports are scheduled to
be available soon: Cancer Pain in December 2008 and Back Pain in January 2009.
With an experienced staff of consultants and analysts, WWMR, Inc. continues to
demonstrate its commitment to providing cost-effective business decision
support to pharmaceutical, biotech, medical device and diagnostics clients who
want to optimize the revenue potential of their product portfolio through
effective business decisions.
For more information about the Pain Clinic Monitor and other services
provided by WWMR, Inc., please contact Michelle Nordstrom, Office and
Production Manager at the Corporate Headquarters:
WWMR, Inc.
2929 Campus Drive
Suite 200
San Mateo, CA 94403
Phone: (888) 947-2339
(650) 513-0300
Fax: (650) 312-1570
Web: http://www.WWMR.com
Email: Michelle_Nordstrom@WWMR.com
'/>"/>SOURCE WWMR, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
Wound Management Technologies, Inc. Announces a Published Case Study2.
Histogen Announces Start of Hair Regrowth Clinical Evaluation3.
New Generation Biofuels Announces Test Burn Agreement With Progress Energy Florida4.
KGI Announces Second Annual Executive Education Conference for Women in Life Sciences5.
SyntheMed Announces FDA Clearance of SinusShield(TM)6.
Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit7.
American HealthChoice Announces the First Sales of the OmniBody Scan8.
Tengion Announces Second Closing of Series C Financing9.
Penguin Computing Announces Niveus HTX Personal Supercomputer 10.
Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference11.
BBM Announces Offer to Acquire YM BioSciences Inc.